MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-08-0002089
Lark Laboratories (India) Ltd - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹77.99 Cr
▼ 16% YoY
Net profit · FY 2024
₹51.29 Lakh
Net margin 0.7%
EBITDA · FY 2024
₹5.83 Cr
EBITDA margin 7.5%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹4.26 Cr
Issued & subscribed
Open charges
₹27.48 Cr
Satisfied ₹32.65 Cr
Company age
47 yrs
Est. 1979
Employees · EPFO
325
Provident fund records
About Lark Laboratories (India) Ltd
Data last updated:
Lark Laboratories (India) Ltd is a public limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 April 1979 and has been in existence for over 47 years.
Its director Virender Uppal and family are #633 among India's richest people (2026). Its director Vijay Kumar uppal and family are #1,320 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL1979PLC009548. Its GSTIN is 07AAACL0407D1Z8 (Delhi). The company holds 4 GST registrations, all of them active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.26 Cr. It was formerly known as Lark Laboratories (India) Private Limited. It is led by directors including Aprajita Takiar (Managing Director) and Vijay Kumar Gupta (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at A – 105/2 Okhla Industrial Areaphase II, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2024, the company reported a revenue of ₹77.99 Cr, a decline of 16% compared to the previous year. For the same year it recorded a net profit of ₹51.29 Lakh (net margin 0.7%) and EBITDA of ₹5.83 Cr (EBITDA margin 7.5%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 6% over five years.
The company has about 325 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Lark Laboratories. As per MCA filings, the company has open charges of ₹27.48 Cr and satisfied charges of ₹32.65 Cr on record. Court records list 78 cases involving the company, including 31 filed by the company and 47 filed against it; 19 cases are pending.
Lark Laboratories (India) Ltd is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0002089). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website larklab.com.
Company details
CIN U24230DL1979PLC009548
Registration Number 009548
Incorporation Date 11 April 1979
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-08-0002089
Key People
Aprajita Takiar Managing Director Vijay Kumar Gupta Whole-Time Director Kantilal Vajeraj Jain Director Recognitions & Rankings of Lark Laboratories (India)
India's Richest People 2026 edition · 2 directors · Source: Hurun India
- #633 Virender Uppal & family ₹5,100 Cr
- #1,320 Vijay Kumar uppal & family ₹1,700 Cr
Contact details
Lark Laboratories (India) Ltd's registered office is in New Delhi, Delhi. Its website is larklab.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressA – 105/2 Okhla Industrial Areaphase II, New Delhi, Delhi, India – 110020
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Lark Laboratories (India) Ltd, buy the company report.
Comprehensive company report
Lark Laboratories (India) Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Lark Laboratories (India) operates one associated brand: Lark Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical formulations manufacturing and distribution in India. | larklab.com |
Business activity
The main business activity of Lark Laboratories (India) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Lark Laboratories (India) Ltd, buy the company report.
Financials of Lark Laboratories (India) Ltd
FY 2024 filings availableLark Laboratories (India) Ltd reported revenue of ₹77.99 Cr (down 16% YoY) for FY 2024.
Revenue · FY 2024
₹77.99 Cr ▼ 16%
Net profit · FY 2024
₹51.29 Lakh margin 0.7%
EBITDA · FY 2024
₹5.83 Cr margin 7.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 16%
3 years · compounded
▲ 2%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▼ 38%
3 years · compounded
▼ 8%
5 years · compounded
▲ 9%
Revenue fell 16% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 6%. EBITDA fell 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹77.99 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.83 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹51.29 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.5% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lark Laboratories (India) Ltd, buy the company report.
Board of directors of Lark Laboratories (India) Ltd
Lark Laboratories (India) has 7 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijay Kumar Gupta | Whole-Time Director | 11 Apr 1979 | 47 Years 6 Months | Current |
| Kantilal Vajeraj Jain | Director | 11 Jul 1981 | 45 Years 3 Months | Current |
| Kamal Prabha Anand Also directs: Spinzer Pharmaceuticals Private Limited | Director | 19 Mar 2002 | 24 Years 7 Months | Current |
| Badri Bishal Tikmani Also directs: Infomedia Publishers Private Limited | Director | 23 Dec 1979 | 46 Years 10 Months | Current |
| Aprajita Takiar | Managing Director | 30 May 1998 | 28 Years 4 Months | Current |
| Vijay Uppal | Director | 11 Apr 1979 | 47 Years 6 Months | Current |
Showing 6 of 7 current directors. View all directors
Peer comparison
Lark Laboratories (India) Ltd is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bharat Immunologicals and Biologicals Corporation Limited | ₹79.49 Cr (FY 2022) | -9.0% | Uttar Pradesh, India | |||
| Swiss Garniers Genexiaa Sciences Private Limited | ₹79.31 Cr (FY 2025) | -12.0% | Chennai, Tamil Nadu, India | |||
| Bochem Healthcare Private Limited | ₹78.45 Cr (FY 2025) | 10.0% | Ujjain, Madhya Pradesh, India | |||
| Lark Laboratories (India) Ltdthis company | ₹77.99 Cr (FY 2024) | ₹51.29 Lakh | 0.7% | -16.0% | 325 | New Delhi, Delhi, India |
| Astra Lifecare (India) Private Limited | ₹77.75 Cr (FY 2019) | -26.0% | Ahmedabad, Gujarat, India | |||
| Universal Medicare Private Limited | ₹77.59 Cr (FY 2025) | 38.0% | Mumbai, Maharashtra, India | |||
| Asence Pharma Private Limited | ₹77.56 Cr (FY 2025) | 19.0% | Vadodara, Gujarat, India | |||
| Vasa Pharma Chem Pvt Ltd | ₹77.38 Cr (FY 2025) | -8.0% | Ahmedabad, Gujarat, India | |||
| Vapi Care Pharma Private Limited | ₹76.81 Cr (FY 2025) | -11.0% | Vapi, Valsad, Gujarat, India |
To see the full peer comparison of Lark Laboratories (India) Ltd, buy the company report.
Auditor
Lark Laboratories (India) Ltd is audited by GSSV & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GSSV & ASSOCIATES | FY 2024 | 014537N |
Shareholding
The shareholding of Lark Laboratories (India) Ltd is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Lark Laboratories (India) Ltd, buy the company report.
Charges & borrowings
Open charges
₹27.48 Cr
Satisfied charges
₹32.65 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Sep 2025 | 101186151 | Hdfc Bank Limited | ₹14.15 Lakh | Open | |
| 15 Jan 2025 | 101057253 | Hdfc Bank Limited | ₹31 Lakh | Open | |
| 21 Nov 2024 | 101012468 | Sidbi | ₹1.4 Cr | Open | |
| 27 Aug 2024 | 100990946 | Hdfc Bank Limited | ₹9.16 Lakh | Open | |
| 27 Feb 2024 | 100870284 | Sidbi | ₹1.5 Cr | Open |
To see the full charge records of Lark Laboratories (India) Ltd, buy the company report.
Total charge records: 41 View all charges
Legal cases
Lark Laboratories (India) Ltd has 78 court cases on record: 31 filed by Lark Laboratories (India), 47 filed against it. 19 cases are pending and 59 are disposed.
Total cases
78
Filed by the company
31
Filed against the company
47
Pending
19
Disposed
59
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 41 | 32 | 7 |
| High courts | 33 | 13 | 10 |
| Supreme Court | 4 | 2 | 2 |
Cases on record (5 of 78)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Court case (RFA(COMM)) | Filed by the company against M/S Delta Air Freight Pvt. Ltd. | Pending |
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed against the company by Wallace Pharmaceuticals Pvt Ltd | Pending |
| High Court, MAHARASHTRA | Court case (LPETN) | Filed against the company by Wallace Pharmaceuticals Pvt Ltd | Pending |
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Wallace Pharmaceuticals Pvt Ltd | Pending |
| District court, Central, Delhi | Interim or miscellaneous application | Filed against the company by Delta Air Freight Pvt Ltd | Disposed |
To see the full case history of Lark Laboratories (India) Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lark Laboratories (India) Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Lark Laboratories (India) Ltd has a workforce of 325 employees on its EPFO records as of Feb 25, 2025, across 2 active EPFO establishments.
Employee count
325
Active EPFO establishments
2
Employee growth
4.5%
GST
Lark Laboratories (India) has 4 GST registrations: 4 active.
Total GSTINs
4
Active
4
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACL0407D1Z8 | Delhi | Active | 01 Jul 2017 |
| 08AAACL0407D1Z6 | Rajasthan | Active | 01 Jul 2017 |
| 10AAACL0407D1ZL | Bihar | Active | 24 May 2018 |
| 29AAACL0407D1Z2 | Karnataka | Active | 24 May 2018 |
To see the full GST registrations and return filing status of Lark Laboratories (India) Ltd, buy the company report.
Recent activity
Lark Laboratories (India) Ltd has 12 board changes on record since 1979: 7 appointments and 5 cessations. The latest: Raj Monga ceased to be Director on 30 May 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.14 Cr with Charge ID 101186151 was registered on 18 Sep 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.31 Cr with Charge ID 101057253 was registered on 15 Jan 2025.
Charges
A charge with Sidbi amounted to Rs. 1.40 Cr with Charge ID 101012468 was registered on 21 Nov 2024.
AGM
Lark Laboratories (India) Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.09 Cr with Charge ID 100990946 was registered on 27 Aug 2024.
Filing
Lark Laboratories (India) Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with Sidbi amounted to Rs. 1.50 Cr with Charge ID 100870284 was registered on 27 Feb 2024.
Charges
A charge with Sidbi amounted to Rs. 2.27 Cr with Charge ID 100870283 was registered on 27 Feb 2024.
Charges
A charge with Sidbi amounted to Rs. 1.56 Cr with Charge ID 100798756 was registered on 23 Oct 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.23 Cr with Charge ID 100675122 was registered on 14 Oct 2022.
Charges
A charge with Others of Rs. 10.45 Cr registered on 29 Sep 2017 with Charge ID 100128298 was modified on 18 Jun 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.28 Cr with Charge ID 100598288 was registered on 31 May 2022.
68 earlier events are in the company report.
Frequently asked questions
Lark Laboratories (India) is an active public limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 April 1979 (47+ years old) and is registered under CIN U24230DL1979PLC009548.
Lark Laboratories (India) has 7 current directors:
- Aprajita Takiar - Managing Director
- Vijay Kumar Gupta - Whole-Time Director
- Kantilal Vajeraj Jain - Director
- Kamal Prabha Anand - Director
- Badri Bishal Tikmani - Director
- Vijay Uppal - Director
- Virender Uppal - Director
The latest financial statements of Lark Laboratories (India) on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Lark Laboratories (India) is 07AAACL0407D1Z8, registered in Delhi. The company has 4 GST registrations in all, of which 4 are active. Other active GSTINs include 08AAACL0407D1Z6 (Rajasthan), 10AAACL0407D1ZL (Bihar), 29AAACL0407D1Z2 (Karnataka).
The CIN (Corporate Identification Number) of Lark Laboratories (India) is U24230DL1979PLC009548. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lark Laboratories (India) has 78 court cases on record: 31 filed by the company and 47 filed against it. 19 are pending. Most are in the district courts.
Lark Laboratories (India) was incorporated on 11 April 1979, making it 47+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Lark Laboratories (India) by revenue are Bharat Immunologicals and Biologicals Corporation Limited, Swiss Garniers Genexiaa Sciences Private Limited, Bochem Healthcare Private Limited, Astra Lifecare (India) Private Limited, Universal Medicare Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Raj Monga ceased to be Director on 30 May 2022. Aprajita Takiar ceased to be Director on 01 Jun 2008. Vijay Kumar Gupta ceased to be Director on 01 Jun 2008. Lark Laboratories (India) has 12 board changes on record in total.
Yes, Lark Laboratories (India) is registered as a small enterprise under Udyam registration (number: UDYAM-DL-08-0002089).
Lark Laboratories (India) can be reached through the website larklab.com. Its registered office is in New Delhi, Delhi, India.